223 related articles for article (PubMed ID: 3321412)
1. Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
Rylander M; Norrby SR; Svärd R
Scand J Infect Dis; 1987; 19(5):551-7. PubMed ID: 3321412
[TBL] [Abstract][Full Text] [Related]
2. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
[TBL] [Abstract][Full Text] [Related]
3. Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
Tungsanga K; Chongthaleong A; Udomsantisuk N; Petcharabutr OA; Sitprija V; Wong EC
Scand J Infect Dis Suppl; 1988; 56():28-34. PubMed ID: 3074463
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Sabbaj J; Hoagland VL; Cook T
Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
[TBL] [Abstract][Full Text] [Related]
5. Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
Wong WT; Chan MK; Li MK; Wong WS; Yin PD; Cheng IK
Scand J Infect Dis Suppl; 1988; 56():22-7. PubMed ID: 3074462
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
Infection; 1989; 17(2):65-9. PubMed ID: 2654019
[TBL] [Abstract][Full Text] [Related]
7. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
Fromtling RA; Abruzzo GK; Gilfillan EC; Pelak BA; Gadebusch HH
J Antimicrob Chemother; 1985 Dec; 16(6):735-41. PubMed ID: 3912365
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
Goldstein EJ; Alpert ML; Najem A; Eng RH; Ginsburg BP; Kahn RM; Cherubin CE
Am J Med; 1987 Jun; 82(6B):65-9. PubMed ID: 3300313
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections].
Ballesteros JJ; Salvador M; Macías J; Honorato J; Rubio A; Azanza JR
Rev Med Univ Navarra; 1988; 32(3):135-7. PubMed ID: 3070683
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the treatment of simple urinary infection with a single dose of norfloxacin versus cotrimoxazole].
de Vevey P; Darioli R; Bille J; Glauser MP
Schweiz Med Wochenschr; 1987 Jun; 117(25):968-73. PubMed ID: 3497450
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
Guerra JG; Falconi E; Palomino JC; Benavente L; Antunez de Mayolo E
Eur J Clin Microbiol; 1983 Jun; 2(3):260-5. PubMed ID: 6224684
[TBL] [Abstract][Full Text] [Related]
13. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Goldstein EJ; Alpert ML; Ginsberg BP
Antimicrob Agents Chemother; 1985 Mar; 27(3):422-3. PubMed ID: 3158277
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole.
Seidmon EJ; Krisch EB; Truant AL; Amy BG; Childs SJ; Hurst AT; McCabe RE
Urology; 1990 Feb; 35(2):187-93. PubMed ID: 2407023
[TBL] [Abstract][Full Text] [Related]
15. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Sabbaj J; Hoagland VL; Shih WJ
Antimicrob Agents Chemother; 1985 Mar; 27(3):297-301. PubMed ID: 3158272
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
Giamarellou H; Tsagarakis J; Petrikkos G; Daikos GK
Eur J Clin Microbiol; 1983 Jun; 2(3):266-9. PubMed ID: 6224685
[TBL] [Abstract][Full Text] [Related]
17. Microbiological perspectives of co-trimoxazole.
Bauernfeind A; Hörl G; Przyklenk B
Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
Watt B; Chait I; Kelsey MC; Newsom SW; Newsom RA; Smith J; Toase PD; Deaney NB; Round EM; Vogel R
J Antimicrob Chemother; 1984 May; 13 Suppl B():89-94. PubMed ID: 6234281
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
20. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
